COVID-19 vaccine delivery and...
The University of Texas MD Anderson Cancer Center is prepared to accept, store and distribute the Pfizer COVID-19 vaccine following the Food and Drug Administration’s decision on Friday, Dec. 11, to grant Emergency Use Authorization. At present, state and local health officials have allocated 4,875 doses of vaccine in the first shipment to MD Anderson for use with frontline health care workers, which is scheduled for delivery on...
Novel antibody-drug conjugate shows promising early results...
ABSTRACT 167
A phase I/II study led by researchers from The University of Texas MD Anderson Cancer Center found IMGN632, a novel...
Stereotactic radiosurgery recommended for patients with...
Researchers from The University of Texas MD Anderson Cancer Center have conducted the first randomized clinical trial comparing...
Lung cancer screening decision aid delivered through tobacco...
In the first comparative clinical trial of lung cancer screening decision aid versus standard educational information, researchers...
